Intuitive Surgical (ISRG) Stock Forecast & Price Target

Compare

8,019 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ISRG Analyst Ratings

Moderate Buy

16 Buy

4 Hold

1 Sell

Based on 21 analysts giving stock ratings to

Intuitive

Surgical

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ISRG Stock 12 Month Forecast

Average Price Target

$603.00

▲(28.28% Upside)

Based on 21 Wall Street analysts offering 12 month price targets for Intuitive Surgical in the last 3 months. The average price target is $603.00 with a high forecast of $685.00 and a low forecast of $440.00. The average price target represents a 28.28% change from the last price of $470.08.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"435":"$435","686":"$686","497.75":"$497.8","560.5":"$560.5","623.25":"$623.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":685,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$685.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":603,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$603.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$440.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[435,497.75,560.5,623.25,686],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,537.99,549.2984615384615,560.6069230769231,571.9153846153846,583.2238461538461,594.5323076923077,605.8407692307692,617.1492307692308,628.4576923076924,639.7661538461539,651.0746153846154,662.3830769230769,673.6915384615385,{"y":685,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,537.99,542.9907692307693,547.9915384615384,552.9923076923077,557.993076923077,562.9938461538461,567.9946153846154,572.9953846153846,577.9961538461539,582.996923076923,587.9976923076923,592.9984615384616,597.9992307692307,{"y":603,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,537.99,530.4523076923077,522.9146153846154,515.376923076923,507.83923076923077,500.3015384615385,492.76384615384615,485.22615384615386,477.6884615384615,470.15076923076924,462.6130769230769,455.0753846153846,447.5376923076923,{"y":440,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":436.24,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":450.94,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":492.63,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":484.76,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":506.34,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.85,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":521.96,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":571.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.15,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":496.36,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":553.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":537.99,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$685.00

Average Price Target$603.00

Lowest Price Target$440.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$601

Buy

27.85%

Upside

Reiterated

07/09/25

Intuitive Surgical's robust financial performance and positive earnings call are the primary drivers of its strong score. The company's strategic initiatives and strong operational metrics provide a solid foundation. However, high valuation and mixed technical indicators suggest some caution. Tariff impacts and international challenges also pose risks to future performance.

Richard NewitterTruist Financial

Truist Financial

$590→$600

Buy

27.64%

Upside

Reiterated

07/23/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Intuitive Surgical (NASDAQ: ISRG), Quest Diagnostics (NYSE: DGX) and Ultragenyx Pharmaceutical (NASDAQ: RARE)

Jayson BedfordRaymond James

Raymond James

$592

Buy

25.94%

Upside

Reiterated

07/23/25

Intuitive Surgical (ISRG) Receives a Buy from Raymond James

Adam MaederPiper Sandler

Piper Sandler

$575→$595

Buy

26.57%

Upside

Reiterated

07/23/25

Piper Sandler Remains a Buy on Intuitive Surgical (ISRG)

Joanne WuenschCiti

Citi

―

Buy

―

Reiterated

07/23/25

We reiterate our Buy on ISRG.

Matt MiksicBarclays

Barclays

$635

Buy

35.08%

Upside

Reiterated

07/23/25

Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Anthony PetroneMizuho Securities

Mizuho Securities

―

Hold

―

Reiterated

07/23/25

Mizuho Securities Keeps Their Hold Rating on Intuitive Surgical (ISRG)

Lee HambrightBernstein

Bernstein

$675→$685

Buy

45.72%

Upside

Reiterated

07/23/25

Bernstein Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

David RescottRobert W. Baird

Robert W. Baird

$590→$600

Buy

27.64%

Upside

Reiterated

07/23/25

Robert W. Baird Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Mike KratkyLeerink Partners

Leerink Partners

$587→$593

Buy

26.15%

Upside

Reiterated

07/23/25

Intuitive Surgical's Strong Performance and Growth Potential Reinforce Buy RatingWe are reiterating our Outperform rating on ISRG and raising our PT to $593 (from $587) following the company's 2Q25 earnings. ISRG put up a solid quarter, with sales and EPS +4% and +14% vs. consensus, respectively. There was plenty to like about the quarter. ISRG delivered 2Q revenue above consensus across all three of its segments, US da Vinci placements came in +3% above consensus, 17% WW procedure growth exceeded our estimate of 16.4%, and ISRG bumped up its FY25 procedure growth and GM guidance ranges. We thought newly appointed CEO Dave Rosa's commentary during Q&A re: remanufactured third-party instruments, the administrative process, and the merits ISRG brings to the table was very well communicated.

Danielle AntalffyUBS

UBS

$547→$585

Hold

24.45%

Upside

Reiterated

07/23/25

Intuitive Surgical price target raised to $585 from $547 at UBSIntuitive Surgical price target raised to $585 from $547 at UBS

Hans EngelErste Group

Erste Group

―

Hold

―

Downgraded

07/23/25

Intuitive Surgical downgraded to Hold from Buy at Erste GroupIntuitive Surgical downgraded to Hold from Buy at Erste Group

Rick WiseStifel Nicolaus

Stifel Nicolaus

$670

Buy

42.53%

Upside

Reiterated

07/23/25

Stifel Nicolaus Keeps Their Buy Rating on Intuitive Surgical (ISRG)Stifel analyst Rick Wise reiterated a Buy rating and $670.00 price target on Intuitive Surgical (NASDAQ: ISRG)

Vijay KumarEvercore ISI

Evercore ISI

$550→$535

Hold

13.81%

Upside

Reiterated

07/23/25

Intuitive Surgical price target lowered to $535 from $550 at Evercore ISIIntuitive Surgical price target lowered to $535 from $550 at Evercore ISI

Brandon VazquezWilliam Blair

William Blair

―

Buy

―

Reiterated

07/23/25

Intuitive Surgical's Strong Financial Performance and Growth Prospects Justify Buy Rating

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$601

Buy

27.85%

Upside

Reiterated

07/09/25

Richard NewitterTruist Financial

Truist Financial

$590→$600

Buy

27.64%

Upside

Reiterated

07/23/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Intuitive Surgical (NASDAQ: ISRG), Quest Diagnostics (NYSE: DGX) and Ultragenyx Pharmaceutical (NASDAQ: RARE)

Jayson BedfordRaymond James

Raymond James

$592

Buy

25.94%

Upside

Reiterated

07/23/25

Intuitive Surgical (ISRG) Receives a Buy from Raymond James

Adam MaederPiper Sandler

Piper Sandler

$575→$595

Buy

26.57%

Upside

Reiterated

07/23/25

Piper Sandler Remains a Buy on Intuitive Surgical (ISRG)

Joanne WuenschCiti

Citi

―

Buy

―

Reiterated

07/23/25

We reiterate our Buy on ISRG.

Matt MiksicBarclays

Barclays

$635

Buy

35.08%

Upside

Reiterated

07/23/25

Barclays Sticks to Their Buy Rating for Intuitive Surgical (ISRG)

Anthony PetroneMizuho Securities

Mizuho Securities

―

Hold

―

Reiterated

07/23/25

Mizuho Securities Keeps Their Hold Rating on Intuitive Surgical (ISRG)

Lee HambrightBernstein

Bernstein

$675→$685

Buy

45.72%

Upside

Reiterated

07/23/25

Bernstein Sticks to Its Buy Rating for Intuitive Surgical (ISRG)

David RescottRobert W. Baird

Robert W. Baird

$590→$600

Buy

27.64%

Upside

Reiterated

07/23/25

Robert W. Baird Keeps Their Buy Rating on Intuitive Surgical (ISRG)

Mike KratkyLeerink Partners

Leerink Partners

$587→$593

Buy

26.15%

Upside

Reiterated

07/23/25

Danielle AntalffyUBS

UBS

$547→$585

Hold

24.45%

Upside

Reiterated

07/23/25

Intuitive Surgical price target raised to $585 from $547 at UBSIntuitive Surgical price target raised to $585 from $547 at UBS

Hans EngelErste Group

Erste Group

―

Hold

―

Downgraded

07/23/25

Intuitive Surgical downgraded to Hold from Buy at Erste GroupIntuitive Surgical downgraded to Hold from Buy at Erste Group

Rick WiseStifel Nicolaus

Stifel Nicolaus

$670

Buy

42.53%

Upside

Reiterated

07/23/25

Stifel Nicolaus Keeps Their Buy Rating on Intuitive Surgical (ISRG)Stifel analyst Rick Wise reiterated a Buy rating and $670.00 price target on Intuitive Surgical (NASDAQ: ISRG)

Vijay KumarEvercore ISI

Evercore ISI

$550→$535

Hold

13.81%

Upside

Reiterated

07/23/25

Intuitive Surgical price target lowered to $535 from $550 at Evercore ISIIntuitive Surgical price target lowered to $535 from $550 at Evercore ISI

Brandon VazquezWilliam Blair

William Blair

―

Buy

―

Reiterated

07/23/25

Intuitive Surgical's Strong Financial Performance and Growth Prospects Justify Buy Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Intuitive Surgical

1 Month

xxx

Success Rate

15/22 ratings generated profit

Average Return

+3.75%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 68.18% of your transactions generating a profit, with an average return of +3.75% per trade.

3 Months

xxx

Success Rate

24/32 ratings generated profit

Average Return

+8.07%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +8.07% per trade.

1 Year

Richard NewitterTruist Financial

Success Rate

27/35 ratings generated profit

Average Return

+27.45%

reiterated a buy rating 18 days ago

Copying Richard Newitter's trades and holding each position for 1 Year would result in 77.14% of your transactions generating a profit, with an average return of +27.45% per trade.

2 Years

xxx

Success Rate

27/34 ratings generated profit

Average Return

+60.79%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 79.41% of your transactions generating a profit, with an average return of +60.79% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ISRG Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ISRG has received 40 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. ISRG average Analyst price target in the past 3 months is 603.00.

Each month's total comprises the sum of three months' worth of ratings.

ISRG Financial Forecast

ISRG Earnings Forecast

Next quarter’s earnings estimate for ISRG is $1.99 with a range of $1.85 to $2.15. The previous quarter’s EPS was $2.19. ISRG beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.65% of the time in the same period. In the last calendar year ISRG has Outperformed its overall industry.

ISRG Sales Forecast

Next quarter’s sales forecast for ISRG is $2.40B with a range of $2.34B to $2.47B. The previous quarter’s sales results were $2.44B. ISRG beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.59% of the time in the same period. In the last calendar year ISRG has Outperformed its overall industry.

ISRG Stock Forecast FAQ

What is ISRG’s average 12-month price target, according to analysts?

Based on analyst ratings, Intuitive Surgical’s 12-month average price target is 603.00.

What is ISRG’s upside potential, based on the analysts’ average price target?

Intuitive Surgical has 28.28% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ISRG a Buy, Sell or Hold?

Intuitive Surgical has a consensus rating of Moderate Buy which is based on 16 buy ratings, 4 hold ratings and 1 sell ratings.

What is Intuitive Surgical’s price target?

The average price target for Intuitive Surgical is 603.00. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $685.00 ,the lowest forecast is $440.00. The average price target represents 28.28% Increase from the current price of $470.08.

What do analysts say about Intuitive Surgical?

Intuitive Surgical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of ISRG?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Intuitive Surgical (ISRG) Stock Forecast & Price Target

ISRG Analyst Ratings

ISRG Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Intuitive Surgical

ISRG Analyst Recommendation Trends

ISRG Financial Forecast

ISRG Earnings Forecast

ISRG Sales Forecast

ISRG Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts